Details for New Drug Application (NDA): 202824
✉ Email this page to a colleague
The generic ingredient in DOXAZOSIN MESYLATE is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Summary for 202824
Tradename: | DOXAZOSIN MESYLATE |
Applicant: | Accord Hlthcare |
Ingredient: | doxazosin mesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202824
Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for 202824
Suppliers and Packaging for NDA: 202824
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 202824 | ANDA | Accord Healthcare Inc. | 16729-211 | 16729-211-01 | 100 TABLET in 1 BOTTLE (16729-211-01) |
DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 202824 | ANDA | Accord Healthcare Inc. | 16729-211 | 16729-211-17 | 1000 TABLET in 1 BOTTLE (16729-211-17) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Jun 11, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Jun 11, 2014 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Jun 11, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription